A crispr-cas system for a lipolytic yeast host cell
AssigneeDsm IP Assets B.V.
InventorsBERNARD MEIJRINK, RENÉ VERWAAL, BIANCA ELISABETH MARIA GIELESEN, JOHANNES ANDRIES ROUBOS
Life of this patent
Estimating the term…
Abstract
The present invention relates to the field of molecular biology and cell biology. More specifically, the present invention relates to a CRISPR-CAS system for a lipolytic yeast host cell.
Claims29
A non-naturally occurring or engineered composition comprising a source of a CRISPR-Cas system comprising a guide-polynucleotide and a Cas protein, wherein the guide-polynucleotide comprises a guide-sequence that essentially is the reverse complement of a target-polynucleotide in a host cell and the guide-polynucleotide can direct binding of the Cas protein at the target-polynucleotide in the host cell to form a CRISPR-Cas complex, wherein the guide-sequence is essentially the reverse complement of the (N)y part of a 5′-(N)yPAM-3′ polynucleotide sequence target in the genome of the host cell, wherein y is an integer of 8-30, wherein PAM is a protospacer adjacent motif, wherein the host cell is a lipolytic yeast, optionally a Yarrowia, optionally a Yarrowia lipolytica, optionally Yarrowia lipolytica CLIB122 or Yarrowia lipolytica ML324 (deposited under number ATCC18943), and wherein PAM is optionally a sequence selected from the group consisting of 5′-XGG-3′, 5′-XGGXG-3′, 5′-XXAGAAW-3′, 5′-XXXXGATT-3′, 5′-XXAGAA-3′, 5′-XAAAAC-3′, wherein X can be any nucleotide or analog thereof, optionally X can be any nucleotide;
- and W is A or T.
Dependencies are inferred from the claim text.